Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aurora Cannabis Inc (ACB) vs Canopy Growth Corp (CGC) Price & Performance

Aurora Cannabis IncTrade
Canopy Growth CorpTrade

Price performance (Past 24H)

Key statistics

Aurora Cannabis Inc vs Canopy Growth Corp — how do they compare? Aurora Cannabis Inc trades at $3.8 (market cap $223.59M), while Canopy Growth Corp trades at $1.03 (market cap $421.10M). The key difference: Canopy Growth Corp is the larger of the two by market cap, and Aurora Cannabis Inc is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.

ACBCGC
Market Cap
$223.59M$421.10M
Sector
HealthHealth
52-Week High
$6.23$1.92
52-Week Low
$2.58$0.86
Enterprise Value
$168.09M$378.55M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aurora Cannabis Inc

Aurora Cannabis (ACB) trades at $3.79, up 31.14% amid a hostile takeover bid from Curaleaf at $4 per share. The stock shows neutral technical signals with bearish moving averages. Fundamentally, 2025 revenue grew to $343.29M with a slim net profit of $1.59M, but 2026 projections indicate a net loss of $120M. Analyst consensus is mixed with 21.43% buy ratings, reflecting uncertainty over the acquisition offer and standalone prospects.

The outlook hinges on the takeover outcome; acceptance could provide immediate upside, while rejection may pressure shares given weak 2026 forecasts. Key risks include execution challenges, regulatory hurdles, and competitive pressures. Investors face a binary event driving near-term volatility.

Canopy Growth Corp

Canopy Growth (CGC) trades at $1.025, up 7.66% with bullish technical signals. The company shows improving fundamentals with Q1 2027 revenue growth of 13% and narrowing losses. Recent acquisitions and cost-cutting initiatives support expansion in medical and European cannabis markets. The stock trades below book value (P/B 0.86) while maintaining a P/S ratio of 1.71.

CGC presents a high-risk turnaround opportunity with improving balance sheet metrics and positive revenue momentum. However, persistent negative earnings and cash flow challenges require careful monitoring. Analyst sentiment remains divided with 33% buy ratings, reflecting the speculative nature of cannabis sector investments amid ongoing regulatory uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

Read more on ACB

About Canopy Growth Corp

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more on CGC